Advertisement
    Earlier today
    Yesterday
    In the last 7 days
    Blood cancers dominate CAR-T pipeline Pharmaceutical Technology04:56 20-Mar-25
    In the last month
    New therapy is ALA CART for resistant disease British Society for Haematology07:16 17-Mar-25
    Seven-hour miracle provides lifeline The Sun Daily19:35 3-Mar-25
    Detailed study of lymphoma acquired from CAR-T therapy British Society for Haematology04:32 3-Mar-25
    Hemogenyx takes major step with AML treatment - ICYMI Proactive Investors (UK)10:23 28-Feb-25
    New CAR-T approved for lymphoma in England British Society for Haematology04:38 24-Feb-25
    view more headlines
    27 Mar 00:30

    About our CAR-T news

    Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.